Co-careldopa (Carbidopa/levodopa)
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (National)
1.5M
NHS Cost
£11.0M
Practices
6,486
Avg per Practice
226
Overview
Co-careldopa (Carbidopa/levodopa) is prescribed by 6,486 GP practices across England. In the last 12 months, 1,465,800 items were prescribed at a total cost of £10,990,106 to the NHS. It is classified under BNF Chapter Central Nervous System, Section Drugs used in parkinsonism and related disorders.
Monthly Prescribing Trend
Jul 2026
120,186
Jul 2026
113,655
Jul 2026
124,107
Jul 2026
120,019
Jul 2026
117,403
Jul 2026
124,655
Jul 2026
120,048
Jul 2026
124,173
Jul 2026
125,534
Jul 2026
111,696
Jul 2026
118,863
Jul 2026
121,649
Prescribing by Area
| Area | Items | Practices | Avg/Practice | vs National |
|---|---|---|---|---|
| NE | 54.0K | 138 | 391 | +73.1% ▲ |
| B | 43.8K | 246 | 178 | -21.2% ▼ |
| BS | 38.4K | 78 | 493 | +118.0% ▲ |
| LE | 31.7K | 123 | 258 | +14.1% ▲ |
| N | 30.3K | 114 | 266 | +17.7% ▲ |
| DN | 29.2K | 86 | 340 | +50.5% ▲ |
| CV | 27.4K | 107 | 256 | +13.3% ▲ |
| GL | 27.3K | 65 | 420 | +85.8% ▲ |
| CM | 26.6K | 68 | 392 | +73.2% ▲ |
| BN | 26.5K | 72 | 368 | +62.7% ▲ |
| NG | 26.0K | 134 | 194 | -14.2% ▼ |
| S | 25.5K | 162 | 157 | -30.4% ▼ |
| HA | 23.8K | 78 | 305 | +35.0% ▲ |
| PO | 23.8K | 62 | 383 | +69.6% ▲ |
| TN | 23.6K | 71 | 332 | +46.8% ▲ |
| E | 23.0K | 133 | 173 | -23.4% ▼ |
| SW | 21.8K | 111 | 196 | -13.2% ▼ |
| HU | 21.4K | 43 | 497 | +120.0% ▲ |
| L | 21.0K | 139 | 151 | -33.1% ▼ |
| ST | 20.2K | 84 | 240 | +6.3% ▲ |
Top Prescribing Practices
| Practice | Items |
|---|---|
| THE RIDINGS MEDICAL GROUP | 3,352 |
| MEDICUS HEALTH PARTNERS | 3,145 |
| THE ROXTON PRACTICE | 2,512 |
BNF Classification
- Chapter: Central Nervous System
- Section: Drugs used in parkinsonism and related disorders
- Paragraph: Dopaminergic drugs used in parkinsonism
Related drugs in this section
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.